You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HSCT

Showing 26 - 50 of 1,779
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-Cell Lymphoblastic Leukemia/Lymphoma Trial in Kunming (Anti-CD19 UCAR-NK cells)

Recruiting
  • B-Cell Lymphoblastic Leukemia/Lymphoma
  • Anti-CD19 UCAR-NK cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 19, 2022

B-cell Lymphoma, B-cell Leukemia Trial in Kunming (anti-CD19 UCAR-NK cells)

Withdrawn
  • B-cell Lymphoma
  • B-cell Leukemia
  • anti-CD19 UCAR-NK cells
  • Kunming, Yunnan, China
    Kunming Hope of Health Hospital
Nov 27, 2022

Viral Infection After HSCT Trial (Virus -specific T cells)

Not yet recruiting
  • Viral Infection After HSCT
  • Virus -specific T cells
  • (no location specified)
Mar 28, 2022

Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

Not yet recruiting
  • Severe Aplastic Anemia
  • (no location specified)
Oct 1, 2023

Pharmacogenetics of VOD in Children With HSCT

Completed
  • Cancer
    • Paris, France
      Robert Debre Hospital
    Apr 15, 2022

    Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

    Recruiting
    • Leukemia, Lymphoid
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 27, 2023

    Alterations in Intestinal Microbiota, Metabolites, and Immune

    Recruiting
    • Graft Vs Host Disease
    • Blood Sample
    • +2 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Nov 16, 2023

    The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or

    Recruiting
    • Acute Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 28, 2022

    EBV Emia and EBV Positive PTLD After Allogenic HSCT Trial in Sanhe (EBV-TCR-T cells)

    Completed
    • EBV Emia and EBV Positive PTLD After Allogenic HSCT
    • EBV-TCR-T cells
    • Sanhe, Hebei, China
      Hebei Yanda Ludaopei Hospital
    Mar 6, 2022

    Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

    Not yet recruiting
    • Leukemia, Lymphoid
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 3, 2023

    GVHD, Chronic, Hematological Malignancy Trial in Copenhagen (Lee Symptom Scala)

    Active, not recruiting
    • GVHD, Chronic
    • Hematological Malignancy
    • Lee Symptom Scala
    • Copenhagen, Denmark
      Rigshospitalet
    Jul 14, 2022

    HLH Trial in Beijing (Teniposide)

    Recruiting
    • HLH
    • Beijing, China
      Zhao Wang
    Sep 15, 2023

    Leukemia, Myeloid, Acute, MDS Trial in Wurzburg (TCM allogeneic humane central memory T cells, cryopreserved)

    Completed
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • TCM allogeneic humane central memory T cells, cryopreserved
    • Wurzburg, Germany
      University Hospital Wuerzburg - Department of Medicine II
    Jul 12, 2022

    Infectious and Noninfectious Lung Diseases Following Allogeneic

    Not yet recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Oct 27, 2023

      Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

      Not yet recruiting
      • Poor Graft Function
      • (no location specified)
      Jun 8, 2023

      The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

      Recruiting
      • Acute Myeloid Leukemia With FLT3/ITD Mutation
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • Guangzhou, Guangdong, China
        Department of Hematology,Nanfang Hospital, Southern Medical Univ
      Oct 25, 2022

      The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

      Recruiting
      • Acute Myeloid Leukemia With FLT3/ITD Mutation
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • Guangzhou, Guangdong, China
        Department of Hematology,Nanfang Hospital, Southern Medical Univ
      Oct 25, 2022

      Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

      Recruiting
      • Myeloid Malignancies
      • fractionated busulfan-based conditioning regimen
      • Chendu, Sichuan, China
        West China Hospital, Sichuan University
      Mar 29, 2023

      Hematopoietic Stem Cell Transplantations Trial in Cincinnati (autoRIC®)

      Recruiting
      • Hematopoietic Stem Cell Transplantations
      • autoRIC®
      • Cincinnati, Ohio
        Cincinnati Children's Hospital
      Feb 1, 2023

      Adult Acute Myeloid Leukemia Trial (mocravimod)

      Not yet recruiting
      • Adult Acute Myeloid Leukemia
      • (no location specified)
      Jun 27, 2022

      PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

      Not yet recruiting
      • PCNSL
      • Shanghai, Shanghai, China
        Ruijin Hospital
      Jun 8, 2023

      Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

      Active, not recruiting
      • Relapsed Adult ALL
      • Relapsed Adult AML
      • Changchun, Jilin, China
        First Hospital of Jilin University
      Nov 19, 2023

      Hematologic Malignancy Trial in Boston (PATH-C)

      Not yet recruiting
      • Hematologic Malignancy
      • PATH-C
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Nov 23, 2023

      CMV Infection or Reactivation After Allogenic HSCT Trial in Sanhe (CMV-TCR-T cells)

      Recruiting
      • CMV Infection or Reactivation After Allogenic HSCT
      • CMV-TCR-T cells
      • Sanhe, Hebei, China
        Hebei Yanda Ludaopei Hospital
      Jan 29, 2022

      Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

      Recruiting
      • Leukemia
      • +2 more
      • applying of FLU+CY post-HSCT
      • Guangzhou, Guangdong, China
        Nanfang Hospital
      Nov 23, 2023